Found another one. Please let me know if these are redundant.

Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection
by ivermectin June 23,2021

https://www.embopress.org/action/cookieA....

Quote:

"They show that IVM administration limits IFN response and lung inflammation, even though defects in the type I IFN pathways have been associated with severe COVID-19"

Quote:

"IVM action is steady and strong in the golden hamsters and is not expected to block the effectors of inflammation but rather to dampen its initiation."

Quote:

"Altogether, this study brings the proof of concept that an IVM-based immunomodulatory therapy improves the clinical condition of SARS-CoV-2-infected hamsters, and in clinical trials, it alleviates symptoms of COVID-19 in humans and possibly limits post- COVID-19 syndrome (also known as long COVID) via an antiinflammatory action."

I guess hamsters get Covid too...